Literature DB >> 8893800

Expression and characterization of equine herpesvirus 1 glycoprotein D in mammalian cell lines.

J E Wellington1, G L Lawrence, D N Love, J M Whalley.   

Abstract

Equine herpesvirus 1 glycoprotein D (EHV-1 gD) expressed constitutively in mammalian cell lines had similar electrophoretic mobility to gD produced in EHV-1 infected cells but lacked a possibly complexed higher molecular weight form seen in the latter. Recombinant gD was N-terminally cleaved at the same site as gD in EHV-1 infected cells and expression was associated with enhanced levels of cell-cell fusion, indicating a role for EHV-1 gD in cell-to-cell transmission of virus.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8893800     DOI： 10.1007/bf01718301

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  34 in total

1.  Amino-terminal sequence, synthesis, and membrane insertion of glycoprotein B of herpes simplex virus type 1.

Authors:  L Claesson-Welsh; P G Spear
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

Review 2.  Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections.

Authors:  G P Allen; J T Bryans
Journal:  Prog Vet Microbiol Immunol       Date:  1986

3.  Use of lambda gt11 and monoclonal antibodies to map the genes for the six major glycoproteins of equine herpesvirus 1.

Authors:  G P Allen; M R Yeargan
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

4.  Equine herpesvirus type 1 unique short fragment encodes glycoproteins with homology to herpes simplex virus type 1 gD, gI and gE.

Authors:  J C Audonnet; J Winslow; G Allen; E Paoletti
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

5.  Herpes simplex virus glycoprotein D mediates interference with herpes simplex virus infection.

Authors:  R M Johnson; P G Spear
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

6.  Immunological memory to herpes simplex virus type 1 glycoproteins B and D in mice.

Authors:  B A Blacklaws; A A Nash
Journal:  J Gen Virol       Date:  1990-04       Impact factor: 3.891

7.  Synthesis and processing of equine herpesvirus 1 glycoprotein D.

Authors:  C C Flowers; S P Flowers; S R Jennings; D J O'Callaghan
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

8.  A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected].

Authors:  A G Langenberg; R L Burke; S F Adair; R Sekulovich; M Tigges; C L Dekker; L Corey
Journal:  Ann Intern Med       Date:  1995-06-15       Impact factor: 25.391

9.  A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells.

Authors:  M W Ligas; D C Johnson
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

10.  Characterization of the glycoprotein D gene products of equine herpesvirus 1 using a prokaryotic cell expression vector.

Authors:  D N Love; C W Bell; J M Whalley
Journal:  Vet Microbiol       Date:  1992-03       Impact factor: 3.293
View more
  2 in total

1.  Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.

Authors:  Shiliang A Liu; Brent A Stanfield; Vladimir N Chouljenko; Shan Naidu; Ingeborg Langohr; Fabio Del Piero; Jacqueline Ferracone; Alma A Roy; Konstantin G Kousoulas
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

Review 2.  The current status and future directions of myxoma virus, a master in immune evasion.

Authors:  Bart Spiesschaert; Grant McFadden; Katleen Hermans; Hans Nauwynck; Gerlinde R Van de Walle
Journal:  Vet Res       Date:  2011-06-09       Impact factor: 3.683
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.